$SRTS

Preview: Sensus Healthcare's Earnings

Sensus Healthcare (NASDAQ: SRTS) is set to release its quarterly earnings on Thursday, 2026-02-12, with analysts expecting an EPS of $-0.07. Investors will be looking for a beat on this estimate and positive forward guidance. Historically, the company's stock has reacted significantly to earnings, with the last quarter seeing a 19.32% increase after beating EPS estimates.

Original reporting
Benzinga · Benzinga Insights, Benzinga Staff Writer
Published Feb 11, 2026, 7:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Feb 11, 2026, 8:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Preview: Sensus Healthcare's Earnings — source image
Decision brief

The 30-second read

$SRTSBearishMed
01

Why it matters

Earnings results could significantly influence short-term stock movements, with potential for increased volatility and trading volume.

02

Market read

The upcoming earnings report is a key event for traders and investors focusing on the medical device sector, with potential implications for related stocks and industry sentiment.

03

What to watch

Potential positive catalysts include strong forward guidance or unexpected operational improvements, which could offset the negative earnings expectation.

Timing: High, as earnings are scheduled for 2026-02-12, with the news published a day prior.

Background

Sensus Healthcare specializes in non-invasive treatment devices, with recent performance influenced by industry trends and technological advancements.

Company-level read

Ticker impact

$SRTSBearishMedium confidence
Context

Primary focus of the news, with significant relevance due to upcoming earnings report.

Expected impact

Potential for increased volatility around earnings; possibility of a short-term rebound if earnings beat expectations or positive guidance is provided.

Evidence & confidence

Given the historical reaction and current analyst expectations, there is a moderate probability of a positive stock movement if the company exceeds earnings estimates or provides optimistic guidance. However, the negative expected EPS and somewhat bearish sentiment suggest caution.

Market effects

The life sciences and medical device sectors may experience increased volatility, especially if Sensus Healthcare's earnings deviate significantly from expectations.

Potential localized impact in the US healthcare and medical device markets, with limited global repercussions unless the company's performance signals broader industry trends.

Low, as Sensus Healthcare is a regional player with a focus on specific medical devices, and the news pertains primarily to its earnings report.

Counterpoint

The market may have already priced in the expected negative EPS, leading to limited downside if earnings meet expectations.

Key entities

  • Sensus Healthcare

    A provider of non-invasive medical devices for skin and superficial tissue treatments.

Related articles

$SRTSMed

Sensus Healthcare, Inc. (SRTS): Results of Operations and Financial Condition

Sensus Healthcare, Inc. (SRTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 g085863_ex99-1.htm EXHIBIT 99-1 Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights Commercial Momentum Builds Following CPT Code Implementation Revenue Recognition on Eight Purchased Units Shifted to Q3 Due to Financing

Med

Prysmian Cable Manufacturing Expands North Carolina Facility

Prysmian is investing over $1 billion to expand its Catawba County, North Carolina facility in Claremont, adding 385 jobs, according to Governor Josh Stein. The expansion is expected to take 20-24 months and more than double U.S. fiber optic capacity, including glass preform and fiber, and increase cable production. Prysmian employs about 680 there.

$NFLXMed

Netflix Shutters Oxenfree Studio Night School just Six Weeks after its Final Horror Game, Unhinged, Hit the Service

Netflix will shut down Night School Studio, developer of Oxenfree and Afterparty, six weeks after releasing Unhinged, and plans to close Moonloot, a Helsinki studio it founded in 2022. Netflix says it is restructuring its internal games team to focus on kids, party, story-driven and mainstream titles, without disclosing job counts. It acquired Night School in 2021.

$NFLXMed

Netflix Kills Oxenfree Studio Right After New Release

Netflix said it is shutting down Night School Studio, acquired in 2021 under Netflix Games, about a month after the release of mobile game Unhinged. Netflix also plans to close Moonloot and cut some internal gaming staff, citing organizational changes to focus on party, kids, mainstream-licensed and story games, according to a Netflix spokesperson.

$HIIMed

Trump orders Navy to abandon carrier launch system, return to steam catapults

Reuters reports that U.S. President Donald Trump ordered the Navy to drop the electromagnetic aircraft carrier launch system and return to steam catapults, via a national security memorandum. The change would require removing the system on Gerald R. Ford-class carriers and is expected to cost billions. Huntington Ingalls is the primary contractor building the Ford class, according to the White House.

$NOCMedAI 8/10

Northrop Grumman gets $158.8 million contract modification

Northrop Grumman (NYSE:NOC) received a $158.8 million contract modification from the U.S. Department of War, according to the agency. The award under contract W58RGZ-26-C-0009 covers definitization, with work at Rolling Meadows, Illinois. Completion is estimated Aug. 13, 2026, and $158.831 million in fiscal 2026 funds were obligated.